Labfit | Labfit participates in a nanotechnology project (DREAM) of the UT Austin Portugal Program

March 30, 2021

DREAM is the name of the project “Drug delivery nanosystem for HPV infection therapy Nanotechnologies”, an exploratory research in the field of nanotechnologies, which emerged as a potential therapeutic approach for viral infection and cancer treatment, specifically, DNA-based nanoparticles for antiviral and/or anticancer drugs that greatly increase their bioavailability and increase their target specificity.